Data Demonstrating Financial Impact of INPEFA® (Sotagli

Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently approved by FDA for treatment of heart failure Abstracts published in the Journal of Managed Care &

Related Keywords

Orlando , Florida , United States , Texas , California , Shanshan Wang , Los Angeles , Craig Granowitz , Jaehong Kim , Lexicon Pharmaceuticals , Drug Administration , Consulting Center , Lexicon Pharmaceuticals Inc , Orlando World Center Marriott , Exchange Commission , National Meeting On , Academy Of Managed Care Pharmacy , Managed Care , Specialty Pharmacy , Managed Care Pharmacy , Opening Night Reception , Expo Hall , Healthcare Economics , Poster Abstracts Supplement , Concomitant Use , Insulin Secretagogues , Mycotic Infections , Glucose Test , Adverse Reactions , Specific Populations , Investor Inquiries ,